<DOC>
	<DOCNO>NCT00406237</DOCNO>
	<brief_summary>Open label , single dose study pharmacokinetics tigecycline adult subject primary biliary cirrhosis ( PBC )</brief_summary>
	<brief_title>Pharmacokinetic Study Of Tigecycline In Adult Subjects With Primary Biliary Cirrhosis</brief_title>
	<detailed_description>pharmacokinetic study</detailed_description>
	<mesh_term>Fibrosis</mesh_term>
	<mesh_term>Liver Cirrhosis</mesh_term>
	<mesh_term>Liver Cirrhosis , Biliary</mesh_term>
	<mesh_term>Tigecycline</mesh_term>
	<mesh_term>Minocycline</mesh_term>
	<criteria>Men nonlactating nonpregnant woman great equal 18 year age Subjects biopsy proven primary biliary cirrhosis ( PBC ) disease asymptomatic symptomatic phase PBC . Otherwise healthy determine investigator basis medical history , physical examination , clinical laboratory test result ( associated PBC ) , vital sign , 12lead electrocardiogram ( ECG ) . Subjects recent increase bilirubin , bilirubin &gt; 15 mg/dL , presence ascites , esophageal varix , hepatic encephalopathy . Any major illness investigator 's judgment substantially increase risk associate subject 's participation study Any malignancy include hepatocellular carcinoma .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2011</verification_date>
</DOC>